J. Kavanagh

发表

Hormonal therapy in ovarian cancer

Wei Hu, J. Kavanagh, S. Fu, 2006, International Journal of Gynecologic Cancer.

Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review

J. Kavanagh, U. Beller, C. Levenback, 2004, International Journal of Gynecologic Cancer.

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

M. Ross, L. Levy, E. Atkinson, 2001, International Journal of Gynecologic Cancer.

Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract.

S. Hewitt, P. Townsend, H. Greenberg, 1989, Gynecologic oncology.

The effect of prolonged cisplatin‐based chemotherapy on progression‐free survival in patients with optimal epithelial ovarian cancer: ‘Maintenance’ therapy reconsidered

J. Wharton, N. Atkinson, M. Mitchell, 1993, Gynecologic oncology.

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

J. Wharton, D. Gershenson, T. Burke, 1991, Gynecologic oncology.

Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract.

J. Fiorica, H. Greenberg, J. Kavanagh, 1991, Gynecologic oncology.

Treatment of metastatic stromal tumors of the ovary with cis‐platin, doxorubicin, and cyclophosphamide

D. Gershenson, J. Kavanagh, L. Copeland, 1987, Obstetrics and gynecology.

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

M. Morris, D. Gershenson, J. Kavanagh, 1992, Gynecologic oncology.

Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina.

L. Delclos, S. Wallace, J. Wharton, 1991, Gynecologic oncology.

Systemic anticancer therapy in gynecological cancer patients with renal dysfunction

D. Gershenson, W. Hu, K. Finkel, 2006, International Journal of Gynecologic Cancer.

What Is the Benefit of Bevacizumab Combined with Chemotherapy in Patients with Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Malignancies?

J. Kavanagh, J. Moroney, C. Levenback, 2009, Journal of chemotherapy.

Transcatheter arterial infusion therapy combined with radical hysterectomy in the treatment of advanced cervical cancer

C. Carrasco, S. Wallace, M. Hiraoka, 2007, CardioVascular and Interventional Radiology.

Combination therapy with leuprolide acetate and tamoxifen in refractory ovarian cancer

R. Freedman, C. Edwards, J. Kavanagh, 1995, International Journal of Gynecologic Cancer.

Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review

A. Malpica, H. Northrup, J. Kavanagh, 2004, International Journal of Gynecologic Cancer.

Phase II Study of Intravenous DX‐8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan

C. Verschraegen, A. Kudelka, E. Loyer, 2000, Annals of the New York Academy of Sciences.

Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer

C. Bueso-Ramos, D. Thomas, H. T. SEE, 2005, International Journal of Gynecologic Cancer.

Ovarian Sertoli-Leydig cell tumor: success with salvage therapy

J. Kavanagh, W. Roberts, M. Finan, 1992, International Journal of Gynecologic Cancer.

Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix

C. Verschraegen, A. Kudelka, D. Kieback, 1996, Anti-cancer drugs.